s Share | I2P: Information to Pharmacists - Archive
Publication Date 01/07/2014         Volume. 6 No. 6   
Information to Pharmacists


From the desk of the editor

Welcome to the July 2014 homepage edition of i2P (Information to Pharmacists) E-Magazine.
At the commencement of 2014 i2P focused on the need for the entire profession of pharmacy and its associated industry supports to undergo a renewal and regeneration.
We are now half-way through this year and it is quite apparent that pharmacy leaders do not yet have a cohesive and clear sense of direction.
Maybe the new initiative by Woolworths to deliver clinical service through young pharmacists and nurses may sharpen their focus.
If not, community pharmacy can look forward to losing a substantial and profitable market share of the clinical services market.
Who would you blame when that happens?
But I have to admit there is some effort, even though the results are but meagre.
In this edition of i2P we focus on the need for research about community pharmacy, the lack of activity from practicing pharmacists and when some research is delivered, a disconnect appears in its interpretation and implementation.

read more
open full screen

Recent Comments

Click here to read...

News Flash

Newsflash Updates for July 2014

Newsflash Updates

Regular weekly updates that supplement the regular monthly homepage edition of i2P. 
Access and click on the title links that are illustrated

Comments: 1

read more
open full screen

Feature Contribution

Woolworths Pharmacy - Getting One Stage Closer

Neil Johnston

It started with “tablet” computers deployed on shelves inside the retailer Coles, specifically to provide information to consumers relating to pain management and the sale of strong analgesics.
This development was reported in i2P under the title Coles Pharmacy Expansion and the Arid PGA Landscape”
In that article we reported that qualified information was a missing link that had come out of Coles market research as the reason to why it had not succeeded in dominating the pain market.
Of course, Woolworths was working on the same problem at the same time and had come up with a better solution - real people with good information.

Comments: 5

read more
open full screen

Intensive Exposition without crossing over with a supermarket

Fiona Sartoretto Verna AIAPP

Editor's Note: The understanding of a pharmacy's presentation through the research that goes into the design of fixtures and fittings that highlight displays, is a never-ending component of pharmacy marketing.
Over the past decade, Australian pharmacy shop presentations have fallen behind in standards of excellence.
It does not take rocket science - you just have to open your eyes.
Recently, our two major supermarkets, Woolworths and Coles, have entered into the field of drug and condition information provision - right into the heartland of Australian Pharmacy.

read more
open full screen

The sure way to drive business away

Gerald Quigley

I attended the Pregnancy, Baby and Children’s Expo in Brisbane recently.
What an eye and ear opening event that was!
Young Mums, mature Mums, partners of all ages, grandparents and friends……...many asking about health issues and seeking reassurances that they were doing the right thing.

Comments: 1

read more
open full screen

‘Marketing Based Medicine’ – how bad is it?

Baz Bardoe

It should be the scandal of the century.
It potentially affects the health of almost everyone.
Healthcare providers and consumers alike should be up in arms. But apart from coverage in a few credible news sources the problem of ‘Marketing Based Medicine,’ as psychiatrist Dr Peter Parry terms it, hasn’t as yet generated the kind of universal outrage one might expect.

read more
open full screen

Community Pharmacy Research - Are You Involved?

Mark Coleman

Government funding is always scarce and restricted.
If you are ever going to be a recipient of government funds you will need to fortify any application with evidence.
From a government perspective, this minimises risk.
I must admit that while I see evidence of research projects being managed by the PGA, I rarely see community pharmacists individually and actively engaged in the type of research that would further their own aims and objectives (and survival).

read more
open full screen

Organisational Amnesia and the Lack of a Curator Inhibits Cultural Progress

Neil Johnston

Most of us leave a tremendous impact on pharmacies we work for (as proprietors, managers, contractors or employees)—in ways we’re not even aware of.
But organisational memories are often all too short, and without a central way to record that impact and capture the knowledge and individual contributions, they become lost to time.
It is ironic that technology has provided us with phenomenal tools for communication and connection, but much of it has also sped up our work lives and made knowledge and memory at work much more ephemeral.

read more
open full screen

Academics on the payroll: the advertising you don't see

Staff Writer

This article was first published in The Conversation and was written by Wendy Lipworth, University of Sydney and Ian Kerridge, University of Sydney
In the endless drive to get people’s attention, advertising is going ‘native’, creeping in to places formerly reserved for editorial content. In this Native Advertising series we find out what it looks like, if readers can tell the difference, and more importantly, whether they care.
i2P has republished the article as it supports our own independent and ongoing investigations on how drug companies are involved in marketing-based medicine rather than evidence-based medicine.

read more
open full screen

I’ve been thinking about admitting wrong.

Mark Neuenschwander

Editor's Note: This is an early article by Mark Neuenschwander we have republished after the soul-searching surrounding a recent Australian dispensing error involving methotrexate.
Hmm. There’s more than one way you could take that, huh? Like Someday when I get around to it (I’m not sure) I may admit that I was wrong about something. Actually, I’ve been thinking about the concept of admitting wrong. So don’t get your hopes up. No juicy confessions this month except that I wish it were easier for me to admit when I have been wrong or made a mistake.
Brian Goldman, an ER physician from Toronto, is host of the award-winning White Coat, Black Art on CBC Radio and slated to deliver the keynote at The unSUMMIT for Bedside Barcoding in Anaheim this May. His TED lecture, entitled, “Doctors make mistakes. Can we talk about it?” had already been viewed by 386,072 others before I watched it last week.

read more
open full screen

Dispensing errors – a ripple effect of damage

Kay Dunkley - BPharm, Grad Dip Hosp Pharm, Grad Dip Health Admin, MPS, MSHPA

Most readers will be aware of recent publicity relating to dispensing errors and in particular to deaths caused by methotrexate being incorrectly packed in dose administration aids.
The Pharmacy Board of Australia (PBA), in its Communique of 13 June 2014, described a methotrexate packing error leading to the death of a patient and noted “extra vigilance is required to be exercised by pharmacists with these drugs”.
This same case was reported by A Current Affair (ACA) in its program on Friday 20 June

read more
open full screen

Take a vacation from your vocation

Harvey Mackay

Have you ever had one of those days when all you could think was, “Gosh, do I need a vacation.”
Of course you have – because all work and no play aren’t good for anyone.
A vacation doesn’t have to be two weeks on a tropical island, or even a long weekend at the beach. 
A vacation just means taking a break from your everyday activities. 
A change of pace. 
It doesn’t matter where.
Everyone needs a vacation to rejuvenate mentally and physically. 
But did you also know that you can help boost our economy by taking some days off? 
Call it your personal stimulus package.

read more
open full screen

Explainer: what is peer review?

Staff Writer

This article was first published in the Conversation. It caught our eye because "peer review" it is one of the standards for evidence-based medicines that has also been corrupted by global pharma.
The article is republished by i2P as part of its ongoing investigation into scientific fraud and was writtenby Andre Spicer, City University London and Thomas Roulet, University of Oxford
We’ve all heard the phrase “peer review” as giving credence to research and scholarly papers, but what does it actually mean?
How does it work?
Peer review is one of the gold standards of science. It’s a process where scientists (“peers”) evaluate the quality of other scientists' work. By doing this, they aim to ensure the work is rigorous, coherent, uses past research and adds to what we already knew.
Most scientific journals, conferences and grant applications have some sort of peer review system. In most cases it is “double blind” peer review. This means evaluators do not know the author(s), and the author(s) do not know the identity of the evaluators.
The intention behind this system is to ensure evaluation is not biased.
The more prestigious the journal, conference, or grant, the more demanding will be the review process, and the more likely the rejection. This prestige is why these papers tend to be more read and more cited.

read more
open full screen

Dentists from the dark side?

Loretta Marron OAM BSc

While dining out with an elderly friend, I noticed that he kept his false tooth plate in his shirt pocket. He had recently had seven amalgam-filled teeth removed, because he believed that their toxins were making him sick; but his new plate was uncomfortable. He had been treated by an 'holistic dentist'. Claiming to offer a "safe and healthier alternative" to conventional dentistry, are they committed to our overall health and wellbeing or are they promoting unjustified fear, unnecessarily extracting teeth and wasting our money?

read more
open full screen

Planning for Profit in 2015 – Your key to Business Success

Chris Foster

We are now entering a new financial year and it’s a great time to reflect on last year and highlight those things that went well and those that may have impacted negatively in the pursuit of your goals.
It's also a great to spend some time re-evaluating your personal and business short, medium and long term goals in the light of events over the last year.
The achievement of your goals will in many cases be dependent on setting and aspiring to specific financial targets. It's important that recognise that many of your personal goals will require you to generate sufficient business profits to fund those aspirations

read more
open full screen

ReWalk™ Personal Exoskeleton System Cleared by FDA for Home Use

Staff Writer

Exoskeleton leader ReWalk Robotics announced today that the U.S. Food and Drug Administration has cleared the company’s ReWalk Personal System for use at home and in the community.
ReWalk is a wearable robotic exoskeleton that provides powered hip and knee motion to enable individuals with Spinal Cord Injury (SCI) to stand upright and walk.
ReWalk, the only exoskeleton with FDA clearance via clinical studies and extensive performance testing for personal use, is now available throughout the United States.

read more
open full screen

Attracting and Retaining Great People

Barry Urquhart

Welcome to the new financial year in Australia.
For many in business the past year has been described as a challenging period.
Adjectives are a key feature of the English language.  In the business lexicon their use can be, and often is evocative and stimulate creative images.  But they can also contribute to inexact, emotional perceptions.
Throughout the financial pages of newspapers and business magazines adjectives abound.
References to “hot” money draw attention and comment.  The recent wave of funds from Chinese investors, keen to remove their wealth from the jurisdiction and control of government regulations is creating a potential property bubble in Australia.

read more
open full screen

Updating Your Values - Extending Your Culture

Neil Johnston

Pharmacy culture is dormant.
Being comprised of values, unless each value is continually addressed, updated or deleted, entire organisations can stagnate (or entire professions such as the pharmacy profession).
Good values offer a strong sense of security, knowing that if you operate within the boundaries of your values, you will succeed in your endeavours.

read more
open full screen

Evidence-based medicine is broken. Why we need data and technology to fix it

Staff Writer

The following article is reprinted from The Conversation and forms up part of our library collection on evidence-based medicines.
At i2P we also believe that the current model of evidence is so fractured it will never be able to be repaired.
All that can happen is that health professionals should independently test and verify through their own investigations what evidence exists to prescribe a medicine of any potency.
Health professionals that have patients (such as pharmacists) are ideally placed to observe and record the efficacy for medicines.
All else should confine their criticisms to their evidence of the actual evidence published.
If there are holes in it then share that evidence with the rest of the world.
Otherwise, do not be in such a hurry to criticise professions that have good experience and judgement to make a good choice on behalf of their patients, simply because good evidence has not caught up with reality.

read more
open full screen

Laropiprant is the Bad One; Niacin is/was/will always be the Good One

Staff Writer

Orthomolecular Medicine News Service, July 25, 2014
Laropiprant is the Bad One; Niacin is/was/will always be the Good One
by W. Todd Penberthy, PhD

(OMNS July 25, 2014) Niacin has been used for over 60 years in tens of thousands of patients with tremendously favorable therapeutic benefit (Carlson 2005).
In the first-person NY Times best seller, "8 Weeks to a Cure for Cholesterol," the author describes his journey from being a walking heart attack time bomb to a becoming a healthy individual.
He hails high-dose niacin as the one treatment that did more to correct his poor lipid profile than any other (Kowalski 2001).

read more
open full screen

Culture Drive & Pharmacy Renewal

Neil Johnston

Deep within all of us we have a core set of values and beliefs that create the standards of behaviour that we align with when we set a particular direction in life.
Directions may change many times over a lifetime, but with life experiences and maturity values may increase in number or gain greater depth.
All of this is embraced under one word – “culture”.
When a business is born it will only develop if it has a sound culture, and the values that comprise that culture are initially inherent in the business founder.
A sound business culture equates to a successful business and that success is often expressed in the term “goodwill” which can be eventually translated to a dollar value.

read more
open full screen

ReWalk™ Personal Exoskeleton System Cleared by FDA for Home Use

Staff Writer

Exoskeleton leader ReWalk Robotics announced today that the U.S. Food and Drug Administration has cleared the company’s ReWalk Personal System for use at home and in the community.
ReWalk is a wearable robotic exoskeleton that provides powered hip and knee motion to enable individuals with Spinal Cord Injury (SCI) to stand upright and walk.
ReWalk, the only exoskeleton with FDA clearance via clinical studies and extensive performance testing for personal use, is now available throughout the United States.

read more
open full screen

Pharmacy 2014 - Pharmacy Management Conference

Neil Johnston

The brave new world of health and wellness is not the enemy of Pharmacy, it is its champion.
Australian futurist, Morris Miselowski, one of the world's leading business visionaries, will present the Opening Keynote address on Pharmacy's Future in the new Health and Wellness Landscape at 2.00pm on Wednesday July 30.
Morris believes the key to better health care could already be in your pocket, with doctors soon set to prescribe iPhone apps, instead of pills.
Technology will revolutionise the health industry - a paradigm shift from healthcare to personal wellness.
Health and wellness applications on smartphones are already big news, and are dramatically changing the way we manage our personal health and everyday wellness.

read more
open full screen

Generation and Application of Community Pharmacy Research

Neil Johnston

Editor’s Note: We have had a number of articles in this issue relating to pharmacy research.
The PGA has conducted a number of research initiatives over the years, including one recently reported in Pharmacy News that resulted from an analysis of the QCPP Patient Questionnaire.
Pharmacy Guild president, George Tambassis, appears to have authored the article following, and there also appears to be a disconnect between the survey report and its target audience illustrated by one of the respondent comments published.
I have asked Mark Coleman to follow through, elaborate and comment:

read more
open full screen

From this page you can share ASMI Media Releases for October 2013 to a social bookmarking site or email a link to the page.
Social Web

ASMI Media Releases for October 2013

Marie Kelly-Davies

articles by this author...

Information and news from the Australian Self Medication Industry (ASMI) provided by Marie Kelly-Davies (ASMI PR Manager). Contact her on 02 9923 9410 or email marie@asmi.com.au

open this article full screen

Advancing Complementary Medicines in Australia:

International regulatory expert Michael Smith to share insights at ASMI Conference


23 October 2013 – The Australian Self Medication Industry (ASMI) will leverage the international experience of pharmacist and licenced naturopathic practitioner Michael Smith at this year’s conference to explore the evolving role of complementary medicines in preventative health.

In Australia, vitamins, mineral and supplements (known as complementary medicines) represent the largest and fastest growing segment in the non-prescription sector, with two-thirds of Australians taking them regularly to optimise their health and wellbeing.

In his session, ‘Complementary Medicines & the Consumer – Then, Now & in the Future’, Michael Smith will focus on the freedom of informed choice and the responsibility of industry to provide consumers with the information they need to make informed choices about their health.

“Complementary medicines are no longer on the fringe of mainstream science and medicine.

Over the past three decades, we have increasingly seen complementary medicines become considered a legitimate healthcare option both in Australia and globally,” said Michael Smith, international regulatory expert and former head of the Office of Complementary Medicines at the Therapeutic Goods Administration (TGA).

“Here in Australia, we are seeing a more discerning, informed and proactive consumer who increasingly considers complementary medicines as part of an approach focussed on personal health and wellbeing. The vast majority of consumers are not substituting conventional medicines with complementary medicines. Rather, vitamins, mineral and supplements are being used as another way to help individuals meet their health goals.”

Mr Smith added that since the claims and indications of many complementary medicines are based on traditional medicine they are often perceived inaccurately as being unproven. While promoting randomised controlled trials is important, they are not practical or necessary in every case. An important task is ensuring that consumers know what type of evidence supports the claims.

“Alongside Canada, Australia has one of the world’s most established regulatory systems for complementary medicines. Consumers in Australia, more than in any other country, can have confidence in the quality and safety of products that are legally sold here.

“What’s important to keep in mind is that the typical consumer is comfortable with complementary medicines so long as they are of high-quality and that the claims are accurately supported by good evidence – scientific or traditional. This supports consumers in making an informed choice around whether to take or not take a complementary medicine.”

Mr Smith’s presentation will also focus on the need to support a regulatory framework that protects the consumer as its primary goal without overburdening the industry given the ‘lower risk’ profile of complementary medicines.

According to ASMI Marketing & Business Development Director, Ms Filomena Maiese, not only does Michael Smith have a remarkable global perspective, his former role at the TGA means he understands the regulatory challenges which exist within the Australian sector.

“Michael Smith’s presentation is set to provide insights on how to continue to promote a viable industry while ensuring the trust and confidence of consumers and healthcare professionals. The timing is critical, with the regulation of complementary medicines undergoing one of the biggest reviews by the TGA,” Ms Maiese said.

Following his presentation, Mr Smith will participate in a panel discussion on complementary medicines with Dr Lesley Braun, Senior Research Fellow, Monash University; Karen Carey,

Chair, Consumer Healthcare Forum (CHF); Prof Scott Koslow, Macquarie University; Dr John Skerritt, National Manager, Therapeutic Goods Administration (TGA); and Dr Lily Tomas, President, Australasian Integrative Medicine Association (AIMA).

To register for the conference and for the full list of conference speakers and topics, please visit www.cvent.com/d/gcqy6c. Regular conference updates will be included on Twitter #ASMIconf.

The ASMI Annual General Meeting will precede the conference at 7.30 am. The conference will be followed with the 2013 ASMI Diamond Awards Dinner at 7.00 pm.


When: Thursday 14 November 2013. Registration and morning tea at 8.30 am

Where: Waterview Convention Centre, Bicentennial Park, Homebush, Sydney

Who: Delegates from all sectors from the consumer healthcare industry are

encouraged to attend

How: Register online at www.cvent.com/d/gcqy6c

Contact: Claire Johnson, ASMI Member Events and Services Associate

02 9922 5111 | claire@asmi.com.au


1. Australian National Audit Office Report No. 3 2011-12. Therapeutic Goods Regulation: Complementary Medicines.


ASMI welcomes Catherine King as Shadow Health Minister

22 October 2013 – The Australian Self Medication Industry (ASMI) has welcomed the appointment of Catherine King as the new Federal Shadow Health Minister in the Labor ministry, just announced by Opposition Leader Bill Shorten.

Ms King replaces Labor's former health minister Tanya Plibersek, who has been elevated on the opposition front bench to Deputy Leader and Foreign Affairs Minister.

Congratulating Ms King on her appointment, ASMI Executive Director Dr Deon Schoombie said:

“ASMI enjoyed a longstanding relationship with Catherine King during her former role as Parliamentary Secretary for Health and Ageing. During this time, Ms King was engaged and accessible on all matters affecting the over-the-counter and complementary medicines industry and ensured that a pragmatic approach was taken to the vast number of regulatory reforms, particularly the labelling and packaging review which is still underway.

“ASMI also congratulates Shayne Neumann on his appointment as Shadow Minister for Ageing and Shadow Minister for Indigenous Affairs.

“Both Ms King and Mr Neumann were instrumental in maintaining open dialogue between the industry and the Therapeutic Goods Administration (TGA) on major issues that impacted the nonprescriptionhealthcare sector. ASMI looks forward to continuing this positive working relationship and keeping both shadow ministers abreast of important developments within the industry.”

Herbal medicines sold legally in Australia assured of high quality

16 October 2013 – Consumers can continue to have confidence in the quality and safety ofcomplementary medicines (herbal medicines, nutritional and dietary supplements) that are legally sold in Australia, the Australian Self Medication Industry (ASMI) has today advised.

ASMI’s comments follow a study published in BMC Medicine which showed herbal medicines that are available in North America frequently contain unlisted ingredients that could pose health risks.

“Two-thirds of all Australians use complementary medicines regularly to optimise their health and wellbeing and to address a range of chronic conditions, with popular examples being fish oil, St John’s Wort and glucosamine,” said ASMI Regulatory and Scientific Affairs Director, Steve Scarff.

“Consumers can be assured that the Australian complementary medicines industry is one of the most tightly regulated in the world, with all products subject to stringent regulations relative to their risk profile. Unlike many other countries in the world, Australia ensures that complementary medicines are manufactured safely and only contain approved, safe ingredients.”

Australia has a two-tiered system for the regulation of medicines, including complementary medicines. Prior to sale, supply or use, higher risk medicines must be ‘Registered’ on the Australian Register of Therapeutic Goods (ARTG), which involves individually evaluating the quality, safety and effectiveness of the product. Lower risk medicines containing pre-approved, low-risk ingredients and

that make limited claims can be ‘Listed’ on the ARTG.The majority of complementary medicines are ‘Listed’ on the ARTG because of their low-riskingredients. Both Registered and Listed medicines must be manufactured to very high standards of quality.

“When a consumer purchases any approved complementary medicine in Australia, they can have

confidence that the ingredients listed on the label are, without doubt, contained in the product.

Unfortunately, it’s a very different picture in many other countries.”

“This is why Australians are advised not to order medicines, including dietary supplements andherbal preparations, over the Internet unless they know exactly what is in the preparation and havechecked the legal requirements for importation and use in Australia.”

Unlike in Australia, there are currently no legal standards for authentication of herbal products inthe United States, which has contributed to an environment of unethical activities within the industry including false advertising, product substitution, contamination and use of undeclared andpotentially allergenic fillers.

While the internet can offer consumers a convenient way to access therapeutic goods, the TGA advises that online purchases of medicines or medical devices should be approached with caution.

Products available on international websites are not regulated by the TGA. If care is not taken,consumers may inadvertently break the law, waste their money or risk their health.

As with all medications, it is important that consumers follow the label instructions and consult with their healthcare practitioner if they have any concerns.


1. Steven G Newmaster et al. DNA barcoding detects contamination and substitution in North American

herbal products. BMC Medicine 2013, 11:222.

2. Therapeutic Goods Administration (TGA). Buying medicines and medical devices over the Internet.

Available at http://www.tga.gov.au/consumers/information-online-internet.htm.


Good bone health relies on calcium and vitamin D working in combination

14 October 2013 – The systematic review and meta-analysis of the effect of vitamin D supplements on bone mineral density conducted by the University of Auckland should not discourage Australians from taking a preventative approach to osteoporosis, the Australian Self Medication Industry (ASMI) said today.

ASMI has urged caution in interpreting the research results, noting that the average population studied in the meta-analysis was neither deficient in calcium nor vitamin D, and that only five of the 23 studies ran for more than two years,1 the period of time that is generally required to accurately measure bone density changes.

As acknowledged by the authors, study sizes varied significantly, from 45 to 421 participants, and some studies might have used inadequate doses of vitamin D or a baseline vitamin D status of the populations studied was not low enough for the intervention to produce a significant effect.1

The variations between studies in the daily vitamin D doses that were investigated are also problematic, with daily doses ranging from 100 to 2000 IU. Some studies investigated very high once-weekly doses, and two studies looked at extremely high once-yearly intramuscular doses.1

ASMI Regulatory and Scientific Affairs Director, Steve Scarff, also highlighted the limitations associated with the review’s heavy focus on the exclusive role of vitamin D in improving bone mass density.

“Calcium and vitamin D are vital nutrients which play a very important role in building and maintaining bone health; these two nutrients work in combination to provide a protective effect against osteoporosis,” said Mr Scarff. “It’s unlikely that the findings will have a major br bearing on the way in which vitamin D supplementation is recommended here in Australia, simply because vitamin D on its own is not part of the standard preventative approach to osteoporosis.”

There is a strong body of scientific evidence which shows that calcium or calcium–vitamin D supplements may be beneficial for general health as well as reducing fracture risk in people who may not be getting enough calcium through their diet.2

“ASMI’s recommendation is for people who are at-risk to speak to a qualified healthcare professional. If they are found to be calcium or vitamin D deficient, supplementation may be recommended as preventative action,” Mr Scarff continued. “What we don’t want to see is people, now and in the future, cutting vitamin D out of their supplement routine and potentially making themselves vulnerable to future fractures.”

At-risk populations include:2,3

* People with naturally very dark skin

* People with little or no sun exposure – e.g. people who hospitalised, living in an aged care

facility or working jobs that prevent sun exposure such as shift workers, miners, or even

office workers working particularly long hours

* People who cover up with long robes and head coverings because of religious or cultural


* Breastfed babies of mothers who have low vitamin D levels

* People with a malabsorption conditions

* Older adults who, due to age, can not synthesise vitamin D as efficiently

* People who are overweight or obese

Osteoporosis is one of Australia’s most debilitating and costly health problems, with approximately 1.2 million people affected.2

For people who aren’t obtaining adequate calcium or vitamin D from natural sources, supplementation is known to be a highly effective way to fill the gap.3

A 2007 Australian study published in The Lancet found that calcium, and calcium in combination with Vitamin D, was associated with a 12% reduction in fractures of all types including hip, vertebrae and wrist.4

In instances where there was a higher compliance rate, the treatment was associated with amuch higher 24% reduction in fractures.4

In Australia and New Zealand, the recommended daily intake of calcium is between 1000 and 1300mg per day for adults. For vitamin D, the National Health & Medical Research Council (NHMRC) considers that dose s of up to 80 mcg* are safe.5

Most supplements that are available in Australia are 25 mcg or less. 


1. Ian R Reid, Mark J Bolland, Andrew Grey. Effects of vitamin D supplements on bone mineral density: a systematic review and meta-analysis. The Lancet. Published online October 11, 2013.

2. Peter R Ebeling et al. Building healthy bones throughout life: an evidence-informed strategy to prevent osteoporosis in Australia. MJA Open 2 Suppl 1. 4 February 2013.

3. Steven Boyages and Kellie Bilinski 2012: Seasonal reduction in vitamin D level persists into spring in NSW Australia: implications for monitoring and replacement therapy. Clinical Endocrinology (2012) 77, 515–523.

4. Tang BM, Eslick GD, Nowson C, Smith C, Bensoussan A. Use of calcium or calcium in combination withvitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analysis.

5. National Health and Medical Research Council. Nutrient Reference Values for Australia and New Zealand Including Recommended Dietary Intakes. 2006.


International digital media expert Jye Smith to guide industry on navigating social media at ASMI’s 2013 Conference

4 October 2013 – With social media reaching into every aspect of Australian lives, the Australian Self Medication Industry (ASMI) has secured international expert Jye Smith to present key insights on “Social Media and the Healthcare Consumer” at its annual conference in Sydney on Thursday 14 November.

With vast experience in digital, PR and healthcare communications, Jye Smith’s passionate approach to online communications and content development throughout his career has led to him being named in B&T's ‘30 Under 30 Leaders of Tomorrow’ and receiving the inaugural Excellence Award from Macleay College Business School.

Returning to the ASMI Conference by popular demand, Jye Smith, Vice President - Digital, Asia Pacific for Weber Shandwick, will also help launch ASMI’s Industry Social Media Guidelines, which will be released shortly for public consultation.

The new guidelines, which represent an industry first, have been developed by ASMI with expert guidance from Jye Smith and the Weber Shandwick team. 

According to ASMI Marketing & Business Development Director, Ms Filomena Maiese:

“Social media has infiltrated every aspect of life, and the healthcare sector is no exception. Here in Australia, social media and online health information have become increasingly important in patient care and consumer decision-making, with a quarter of Australians regularly seeking health information online. 

“To date, the consumer healthcare industry has been quite cautious in engaging with social media, mainly due to the highly complex regulated environment of health communication, and the fact that this is still an evolving channel. 

“Having worked closely with ASMI’s Marketing & Ethics Subcommittee for the past year, Jye will give conference delegates a comprehensive overview of how social media can enhance the consumer healthcare sector by encouraging a more empowered and informed health consumer.He will also outline how the new draft industry social media guidelines fit into this evolvingspace.”

 To register for the conference and for the full list of conference speakers and topics, please visit www.cvent.com/d/gcqy6c. Regular conference updates will be included on Twitter #ASMIconf.

 The ASMI Annual General Meeting will precede the conference at 7.30 am. The conference willbe followed with the 2013 ASMI Diamond Awards Dinner at 7.00 pm.


When: Thursday 14 November 2013. Registration and morning tea at 8.30 am

Where: Waterview Convention Centre, Bicentennial Park, Homebush, Sydney

Who: Delegates from all sectors from the consumer healthcare industry are

encouraged to attend

How: Register online at www.cvent.com/d/gcqy6c

Contact: Claire Johnson, ASMI Member Events and Services Associate

02 9922 5111 | claire@asmi.com.au

health news headlines provided courtesy of Medical News Today.

Click here to

If any difficulty is found in subscribing, please use the "Contact Us" panel found in the navigation bar with the message "subscribe" and your email address.

Subscribe to our mailing list

Email Format


  • Copyright (C) 2000-2020 Computachem Services, All Rights Reserved.

Website by Ablecode